4/A//SEC Filing
Cockroft Bettina M. 4/A
Accession 0001683168-23-007108
CIK 0001729427other
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 6:00 PM ET
Size
8.5 KB
Accession
0001683168-23-007108
Insider Transaction Report
Form 4/AAmended
Cockroft Bettina M.
Director
Transactions
- Award
Option to purchase common stock
2023-09-21+9,475→ 18,074 totalExercise: $1.09Exp: 2033-09-22→ Common Stock (9,475 underlying) - Award
Option to purchase common stock
2023-09-14+6,500→ 8,599 totalExercise: $2.27Exp: 2033-09-14→ Common Stock (6,500 underlying)
Footnotes (3)
- [F1]The stock options set forth in this table vest in 36 equal monthly installments. The stock option was approved by the compensation committee of the company's board of directors on August 4, 2023, subject to shareholder approval of the 2020 Stock Plan under which the option was granted. The shareholders of the company approved the plan at the company's annual meeting on September 14, 2023.
- [F2]The stock options were issued in connection with the reporting person's Board of Director services to the Company.
- [F3]The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date.
Documents
Issuer
CNS Pharmaceuticals, Inc.
CIK 0001729427
Entity typeother
Related Parties
1- filerCIK 0001900452
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 11, 8:00 PM ET
- Accepted
- Oct 12, 6:00 PM ET
- Size
- 8.5 KB